Medical/Pharmaceuticals
neoX Biotech closes US$30 million Series A round
BEIJING, Feb. 9, 2021 /PRNewswire/ -- neoX Biotech, a next-generation biotech company specializing in computational design for novel drug research and development, recently announced that it had raisedUS$30 million in Series A funding.The financing was co-led by Sky9 Capital and 5Y Capital (forme...
2021-02-09 21:28
3148
Regent Pacific's Strategic Partner Obtains Clinical Trial Approval for FORTACIN(TM)
HONG KONG, Feb. 9, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Biopharmaceutical...
2021-02-09 20:35
8041
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China
TORONTO and SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF) today announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in theGreater China region. Nuance is a biopharmaceutical company focused on licensing, developing and com...
2021-02-09 20:00
5465
Guide IR Ranks Top 2 in Yole Report as Global Infrared Thermal Imaging Market Explodes
WUHAN, China, Feb. 9, 2021 /PRNewswire/ -- Yole Développement, the internationally renowned market survey and strategic consulting firm, has launched its latest industry analysis entitled Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary Report. The report reveals that ...
2021-02-09 19:26
2572
Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter
STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...
2021-02-09 16:30
1781
Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China
SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Yingli Pharma announced today that it reached strategic collaboration with Hengrui Medicine (600276.SH), a partnership which will significantly accelerate the expansion of Yingli Pharma's oncology business inChina, the second largest pharmaceutical market in...
2021-02-09 08:30
1807
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics
* Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiate any project within four weeks * Offer flexible large-scale manufacturing services by implementing Scale-out strategy WUXI, China, Feb. 9, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.H...
2021-02-09 08:25
2230
Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma
SAN FRANCISCO and SUZHOU, China, Feb. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-02-09 08:00
8216
Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development
RENO, Nev., Feb. 9, 2021 /PRNewswire/ -- Bioelectronica Corporation ("Bioelectronica") today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The ...
2021-02-09 04:46
2878
8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021
Frost & Sullivan experts present strategic insights on key trends such as virtual care, vaccines, hospital efficiency solutions, digital biomarkers, and microbiome therapeutics SANTA CLARA, Calif., Feb. 9, 2021 /PRNewswire/ -- Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving b...
2021-02-09 01:43
272
Inova Appoints Claude Basset as Chief Product Officer
LYON, France, Feb. 8, 2021 /PRNewswire/ -- Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude Basset has joined their leadership team as Chief Product Officer. Inova is a French Tech success story that, now in its 10th year, ha...
2021-02-08 16:00
1356
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)
First Patient to Receive ORL-101 in Israel This Week BAAR, Switzerland, Feb. 8, 2021 /PRNewswire/ -- Orpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a novel ...
2021-02-08 15:00
2308
Zamst announces sponsorship with Yuji Nishida, Professional Volleyball Player
TOKYO, Feb. 8, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., owner of Zamst, a
brand of athletic braces and care products headquartered inTokyo, Japan, has
entered a sports sponsorship agreement withYuji Nishida, Japanese men's
professional volleyball player for JTEKT Stings in V.League.
2021-02-08 14:00
5172
A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan
TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study inJapan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin). Kyowa Kirin initiated the clinica...
2021-02-08 09:00
3287
Hidrox(R), a proprietary olive polyphenols formulation may help in managing COVID-19 pandemic
HAYWARD, Calif., Feb. 6, 2021 /PRNewswire/ -- Oliphenol LLC, Hayward, California , announces the publication of a discovery focused upon the SARS-CoV-2-inactivating activity of Hidrox®, an olive polyphenols formulation for a potential treatment against SARS-CoV-2 infection. The Paper, "The SARS-C...
2021-02-06 00:17
3003
Report offers checkup on health of Chinese people in 2020
HANGZHOU, China, Feb. 5, 2021 /PRNewswire/ -- Over 60 percent of respondents held a positive attitude toward the prospects of China's healthcare system and the potential for technologies, a health report found. China Daily app and DX Doctor (DXY), a health information sharing platform, published...
2021-02-05 13:08
2630
TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders
AUSTIN, Texas, Feb. 5, 2021 /PRNewswire/ -- Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for...
2021-02-05 12:20
2481
Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held
HONG KONG, Feb. 5, 2021 /PRNewswire/ -- Exclusively represented by Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460), Letybo®100U, a type A botuli...
2021-02-05 11:32
5115
DFI Joins Hands with German ACL to Develop Substantial Business Opportunities in the Smart Medical Market
TAIPEI, Feb. 5, 2021 /PRNewswire/ -- DFI, a leading industrial computer manufacturer, has entered a strategic alliance with ACL, a well-known German medical IT hardware manufacturer, and will combine with DFI's 40 years of rich experience in industrial computers. ACL has been famous in the medica...
2021-02-05 09:00
2417
Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care
GENEVA, Feb. 5, 2021 /PRNewswire/ -- The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to treat liver cancer patients, cancellations of surgery, and a drop in the number of patients entered on clinical trials, were just some of the is...
2021-02-05 07:00
2462
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709